That means current switching protocols come from trial designs and the expected behavior based on retatrutides pharmacology: 6-day half-life, triple receptor activity (GLP-1 plus GIP plus glucagon), and stepwise titration from 2 mg to 12 mg
Guimaraes R, Barros L, Carvalho AM, Ferreira I
A September 2023 profile in Science [15], followed in short order by stories in STAT [16, 17], identified Mojsov to a wide scientific readership as someone whose foundational contributions were being overlooked
Its a pen with a needle, so its supposed to be disposed of in a sharps container, Ali said
MT-II treatment, n = 9)
Mild fluid retention some patients experience mild water retention, particularly in the first 2 to 4 weeks